William Brady

8.2k total citations · 5 hit papers
28 papers, 7.0k citations indexed

About

William Brady is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, William Brady has authored 28 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in William Brady's work include T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). William Brady is often cited by papers focused on T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). William Brady collaborates with scholars based in United States, Germany and Denmark. William Brady's co-authors include Peter S. Linsley, J A Ledbetter, Laura S. Grosmaire, Nitin K. Damle, P S Linsley, J A Ledbetter, Jürgen Bajorath, Alejandro Aruffo, Robert Peach and Jeffrey A. Bluestone and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

William Brady

28 papers receiving 6.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CTLA-4 is a second receptor for the B cell activation antigen B7.

1991 1.4k citations Peter S. Linsley, William Brady et al. The Journal of Experimental Medicine profile →
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

1991 1.0k citations P S Linsley, William Brady et al. The Journal of Experimental Medicine profile →
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg

1992 966 citations William Brady, Peter S. Linsley et al. profile →
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1992 912 citations Lieping Chen, William Brady et al. Cell profile →
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors

1994 786 citations P S Linsley, William Brady et al. Immunity profile →

Peers

Countries citing papers authored by William Brady

Since Specialization

Citations

This map shows the geographic impact of William Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Brady more than expected).

Fields of papers citing papers by William Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Brady. The network helps show where William Brady may publish in the future.

Co-authorship network of co-authors of William Brady

This figure shows the co-authorship network connecting the top 25 collaborators of William Brady. A scholar is included among the top collaborators of William Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Brady. William Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model 2015 ·Protein Engineering Design and Selection ·Karin Stenderup, Cecilia Rosada, Kurt Shanebeck, William Brady, (unknown), Gordon J. King, Marcello Marelli, (unknown), Hengyu Xu, (unknown), Jeffrey Johnson, (unknown), Gary Li, (unknown), Tomas Norman Dam, Kenneth H. Grabstein	14
2	Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys 2011 ·Lara D. Veeken ·Cheryl Nickerson‐Nutter, Lioudmila Tchistiakova, Nilufer P. Seth, Marion T. Kasaian, (unknown), Stéphane Olland, Richard Zollner, William Brady, K M Mohler, Peter Baum, Alan F. Wahl, Donna L. Herber, Yulia Vugmeyster, (unknown), Neil M. Wolfman, Davinder Gill, Mary Collins, Kyriaki Dunussi‐Joannopoulos	6
3	CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells 2009 ·Clinical Cancer Research ·Martha Hayden-Ledbetter, (unknown), Erik Espling, William Brady, Laura S. Grosmaire, Philip Tan, (unknown), (unknown), C. Nilsson, D. Barone, (unknown), (unknown), Peter A. Thompson, Alan F. Wahl, Jeffrey A. Ledbetter	27
4	Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation 2004 ·Journal of Clinical Investigation ·Ashish Jain, Chi A., Eduardo López‐Granados, Gary Means, William Brady, Jordan S. Orange, Shuying Liu, Steven M. Holland, Jonathan M.J. Derry	67
5	Characterization of Human Inducible Costimulator Ligand Expression and Function 2000 ·The Journal of Immunology ·Alexandra Aicher, Martha Hayden-Ledbetter, William Brady, Antonio Pezzutto, Günther Richter, Dario Magaletti, (unknown), Jeffrey A. Ledbetter, Edward A. Clark	205
6	Cloning, Characterization, and Modeling of Mouse and Human Guanylate Kinases 1996 ·Journal of Biological Chemistry ·William Brady, Mark Kokoris, (unknown), Margaret E. Black	40
7	Binding Stoichiometry of the Cytotoxic T Lymphocyte-associated Molecule-4 (CTLA-4) 1995 ·Journal of Biological Chemistry ·Peter S. Linsley, Steven G. Nadler, Jürgen Bajorath, Robert Peach, (unknown), (unknown), Jeff Bradshaw, M. R. Stebbins, Gina Leytze, William Brady, Alison R. Malacko, Hans Marquardt, (unknown)	90
8	Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. 1994 ·The Journal of Experimental Medicine ·Robert Peach, Jürgen Bajorath, William Brady, Gina Leytze, (unknown), Joseph Naemura, Peter S. Linsley	201
9	Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell. 1994 ·The Journal of Immunology ·Roger Sciammas, Raymond M. Johnson, Anne I. Sperling, William Brady, Peter S. Linsley, Patricia G. Spear, F W Fitch, Jeffrey A. Bluestone	142
10	Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors breakdown → 1994 ·Immunity ·P S Linsley, (unknown), William Brady, Jürgen Bajorath, J A Ledbetter, Robert Peach	786
11	Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system. 1994 ·PubMed ·(unknown), Peter S. Linsley, Margit Gayle, Jürgen Bajorath, William Brady, Nancy Norris, H. Perry Fell, J A Ledbetter, Lisa K. Gilliland	43
12	Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. 1993 ·The Journal of Immunology ·Andrew Nelson, Suzanne Hosier, William Brady, Peter S. Linsley, Andrew G. Farr	60
13	Phorbol-12-Myristate-13-Acetate-Treated Human Keratinocytes Express B7-Like Molecules That Serve a Costimulatory Role in T-Cell Activation 1993 ·Journal of Investigative Dermatology ·(unknown), Andrea Dietrich, R Niedner, Alexander Kapp, Erwin Schöpf, Jeffrey A. Ledbetter, William Brady, P S Linsley, Jan C. Simon	39
14	Co‐stimulation of murine CD4 T cell growth: cooperation between B7 and heat‐stable antigen 1992 ·European Journal of Immunology ·Yang Liu, (unknown), William Brady, Charles A. Janeway, (unknown)	126
15	Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 breakdown → 1992 ·Cell ·Lieping Chen, (unknown), William Brady, (unknown), Karl Erik Hellström, J A Ledbetter, Patrick O. McGowan, Peter S. Linsley	912
16	Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. breakdown → 1991 ·The Journal of Experimental Medicine ·P S Linsley, William Brady, Laura S. Grosmaire, Alejandro Aruffo, Nitin K. Damle, J A Ledbetter	1003
17	CTLA-4 is a second receptor for the B cell activation antigen B7. breakdown → 1991 ·The Journal of Experimental Medicine ·Peter S. Linsley, William Brady, (unknown), Laura S. Grosmaire, Nitin K. Damle, J A Ledbetter	1423
18	Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies. 1986 ·The Journal of Experimental Medicine ·U Storb, Carl A. Pinkert, B Arp, Peter Engler, Katherine A. Gollahon, (unknown), William Brady, Ralph L. Brinster	120
19	Performances of Articulatory Defective, Minimal Brain Dysfunctioning, and Normal Children on Dichotic Ear Preference, Laterality, and Fine-Motor Skills Tasks 1976 ·The Journal of Special Education ·Ronald K. Sommers, W.H. Moore, William Brady, (unknown)	7
20	Dichotic Ear Preferences of Stuttering Children and Adults 1975 ·Perceptual and Motor Skills ·Ronald K. Sommers, William Brady, W.H. Moore	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact